retatrutide blindness vs Ozempic: Clinical Trial Comparisons Retatrutide Cause Blindness

Khnke et al., 2009

These three mechanisms make retatrutide the most potent GLP-1 therapy currently in development, and the most potent

Research suggests more than 40% of American adults have experienced weight stigma and family members are often guilty of shaming their loved ones, intentionally or not

(2018) 13:e0198046

Hers is a direct-to-consumer telehealth brand that helps people access GLP-1 medications for weight loss without the usual hurdles of lab work, referrals, or insurance approval

At present, direct clinical evidence supporting combined use of GLP-1 therapies with NIR or methylene blue in dementia is limited, and claims of additive or synergistic benefit remain hypothetical